GHK-Cu and Apixaban Interaction: Safety, Pharmacology, and Clinical Guidance
Is it safe to take GHK-Cu (copper tripeptide) with apixaban (Eliquis)? A pharmacologist-level review of CYP3A4, P-gp, and coagulation overlap between these two agents.
Ghk Cu: Drug Interactions
29 source-based articles maintained by the HealthRX.com Editorial Team.
29articles
3topic areas covered
May 25, 2026latest review
Ghk Cu: Drug Interactions library
Showing 29 of 29 clinical reviews.
GHK-Cu and Atorvastatin Interaction: What Clinicians and Patients Need to Know
A detailed guide to the GHK-Cu and atorvastatin interaction, covering CYP3A4 pharmacokinetics, copper metabolism, safety data, and practical dosing guidance.
GHK-Cu and Benzodiazepines Interaction: Safety, Risks, and Clinical Guidance
Can you take GHK-Cu with benzodiazepines? A analysis of the copper tripeptide GHK-Cu and benzodiazepine interaction, covering mechanisms, safety data, monitoring, and dose adjustment.
GHK-Cu and Bupropion Interaction: What Clinicians and Patients Need to Know
A clinician-level review of the GHK-Cu and bupropion interaction, covering CYP2D6 pharmacokinetics, seizure-threshold pharmacodynamics, monitoring parameters, and patient counseling guidance with primary-source citations.
GHK-Cu and Clopidogrel Interaction: Safety, Mechanisms, and Clinical Guidance
Can you take GHK-Cu with clopidogrel? A look at the pharmacokinetic and pharmacodynamic interaction profile between copper tripeptide GHK-Cu and the antiplatelet drug clopidogrel.
GHK-Cu and Diphenhydramine Interaction: What Clinicians and Patients Should Know
Is it safe to combine GHK-Cu (copper tripeptide) with diphenhydramine? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and patient counseling points.
GHK-Cu and Estradiol HRT Interaction: Safety, Mechanisms, and Clinical Guidance
Can you take GHK-Cu (copper tripeptide) with estradiol hormone replacement therapy? Review of pharmacokinetic and pharmacodynamic interactions, safety data, monitoring recommendations, and clinical guidance.
GHK-Cu and Finasteride Interaction: Safety, Mechanisms, and Clinical Guidance
Board-reviewed analysis of the GHK-Cu (copper tripeptide) and finasteride interaction, covering pharmacokinetic and pharmacodynamic profiles, safety data, monitoring, and practical guidance for patients using both compounds.
GHK-Cu and Gabapentin Interaction: Safety, Pharmacology, and Clinical Guidance
Evidence-based review of potential interactions between copper tripeptide GHK-Cu and gabapentin, covering pharmacokinetic pathways, pharmacodynamic overlap, monitoring parameters, and clinical recommendations.
GHK-Cu and Hormonal Contraceptives: What the Evidence Actually Shows
A look at whether GHK-Cu (copper tripeptide) interacts with hormonal contraceptives, covering mechanism, copper physiology, CYP enzymes, and safe-use guidance.
GHK-Cu and Levothyroxine Interaction: Safety, Absorption, and Clinical Guidance
Can you take GHK-Cu with levothyroxine? A guide covering copper tripeptide absorption interactions, thyroid hormone binding, monitoring protocols, and dose-timing strategies.
GHK-Cu and Metformin Interaction: Safety, Mechanisms, and Clinical Guidance
Is it safe to take GHK-Cu (copper tripeptide) with metformin? A guide covering pharmacokinetic mechanisms, monitoring recommendations, and practical dosing advice.
GHK-Cu and NSAIDs (Ibuprofen, Naproxen): Interaction Risk, Safety, and Clinical Guidance
Can you take GHK-Cu with NSAIDs like ibuprofen or naproxen? Review the pharmacologic interaction profile, shared anti-inflammatory pathways, copper-mediated GI and renal considerations, and monitoring recommendations.
GHK-Cu and Opioids (Oxycodone, Hydrocodone, Tramadol): Interaction Guide
Board-reviewed guide to combining copper tripeptide GHK-Cu with opioids including oxycodone, hydrocodone, and tramadol. Covers pharmacokinetic and pharmacodynamic interaction data, monitoring, and clinical recommendations.
GHK-Cu and PPIs (Omeprazole, Pantoprazole): Interaction Guide
A guide covering the pharmacokinetic and pharmacodynamic interaction between GHK-Cu copper tripeptide and proton pump inhibitors including omeprazole and pantoprazole, with monitoring and dosing guidance.
GHK-Cu and Prednisone Interaction: Safety, Risks, and Clinical Guidance
Can you take GHK-Cu with prednisone? A guide covering the pharmacological interaction between copper tripeptide GHK-Cu and prednisone, including mechanism overlap, monitoring parameters, and dose-adjustment considerations.
GHK-Cu and Pregabalin Interaction: What Patients and Clinicians Need to Know
A analysis of the GHK-Cu and pregabalin interaction, covering pharmacokinetics, pharmacodynamics, CNS risk, monitoring, and patient counseling.
GHK-Cu and Progesterone HRT Interaction: Safety, Mechanisms, and Clinical Guidance
Can you take GHK-Cu with progesterone HRT? A guide covering pharmacokinetic and pharmacodynamic overlap, monitoring recommendations, and patient counseling for copper tripeptide GHK-Cu used alongside progesterone hormone replacement therapy.
GHK-Cu and Rivaroxaban Interaction: Safety, Risks, and Clinical Guidance
Can you take GHK-Cu (copper tripeptide) with rivaroxaban? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and clinical evidence.
GHK-Cu and Rosuvastatin Interaction: Safety, Mechanisms, and Clinical Guidance
Is it safe to take GHK-Cu (copper tripeptide) with rosuvastatin? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment considerations.
GHK-Cu and Sildenafil Interaction: Safety, Mechanism, and Clinical Guidance
Is it safe to take GHK-Cu (copper tripeptide) with sildenafil? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment guidance.
GHK-Cu and Simvastatin Interaction: Safety, Risks, and Clinical Guidance
Is it safe to take GHK-Cu (copper tripeptide) with simvastatin? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose considerations.
GHK-Cu and SNRIs (Venlafaxine, Duloxetine) Interaction: What Clinicians and Patients Need to Know
A guide to the pharmacokinetic and pharmacodynamic interaction profile between copper tripeptide GHK-Cu and SNRI antidepressants venlafaxine and duloxetine, including mechanism, monitoring, and dosing guidance.
GHK-Cu and SSRIs (Sertraline, Escitalopram): Interaction Risk, Safety, and Clinical Guidance
Is it safe to combine GHK-Cu (copper tripeptide) with SSRIs like sertraline or escitalopram? A clinician-grade review of pharmacokinetic and pharmacodynamic interaction data, monitoring protocols, and dose considerations.
GHK-Cu and Tadalafil Interaction: Safety, Mechanisms, and Clinical Guidance
Is it safe to combine GHK-Cu (copper tripeptide) with tadalafil? Review of pharmacokinetic and pharmacodynamic interaction potential, monitoring recommendations, and clinical evidence.
GHK-Cu and Testosterone Interaction: What Patients and Clinicians Need to Know
A guide covering the pharmacokinetic and pharmacodynamic interaction profile of GHK-Cu (copper tripeptide) combined with testosterone therapy, including monitoring parameters, safety data, and clinical decision-making.
GHK-Cu and Trazodone Interaction: Safety, Risks, and Clinical Guidance
Can you take GHK-Cu with trazodone? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring parameters, and dose-adjustment strategies for copper tripeptide GHK-Cu used alongside trazodone.
GHK-Cu and Warfarin Interaction: What Patients and Clinicians Need to Know
A guide to the GHK-Cu and warfarin interaction, covering mechanism, INR monitoring, dose-adjustment principles, and patient counseling based on primary literature.
GHK-Cu and Zolpidem Interaction: Safety, Mechanisms, and Clinical Guidance
Evidence-based analysis of the interaction profile between copper tripeptide GHK-Cu and zolpidem (Ambien), covering pharmacokinetic pathways, severity assessment, and monitoring recommendations.